Peter MacCallum Cancer Centre — Melbourne, Victoria

Public research footprint of Peter MacCallum Cancer Centre, compiled from the ClinicalTrials.gov public registry.

525

Registered studies

267

Active

142

Recruiting now

163

Completed

Stopped or withdrawn

Most-studied conditions

KRAS Altered Advanced or Metastatic Solid Tumors · Advanced or Metastatic Non-small Cell Lung Cancer · Recurrent Skin Squamous Cell Carcinoma With Sarcomatoid… · Recurrent Skin Acantholytic Squamous Cell Carcinoma

Recently updated registry entries

NCT06768489 — A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or… (Recruiting)
NCT01804686 — A Long-term Extension Study of PCI-32765 (Ibrutinib) (Recruiting)
NCT05217446 — A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Peter MacCallum Cancer Centre?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.